Takeyoshi I, Iwanami K, Yamada T, Kawate S, Hamada K, Sunose Y, Yoshida M, Horiguchi J, Ohwada S, Sasaki A, Morishita Y: Advanced gastric cancer with peritoneal dissemination successfully treated with paclitaxel and doxifluridine: a case report. Hepatogastroenterology 52:322-325,2005
Ninomiya J, Oyama T, Horiguchi J, Koibuchi Y, Yoshida T, Iijima K, Yoshida M, Takata D, Iino Y, Morishita Y: Two case of breast cancer with cartilaginous and osseous metaplasia. Breast Cancer 12:52-56,2005
Horii Y, Iino Y, Maemura M, Horiguchi J, Morishita Y: Inhibitory effects of OK-432 (Picibanil) on cellular proliferation and adhesive capacity of breast carcinoma cells. Oncol Rep 13:289-294,2005
Takeyoshi I, Makita F, Tanahashi Y, Yokomori T, Iwazaki S, Kawashima Y, Iwanami K, Yamada T, Kawate S, Hamada K, Sunose Y, Yoshida M, Horiguchi J, Iesato H, Kobayashi M, Morishita Y: A combination phase I study of weekly paclitaxel and doxifluridine in advanced gastric cancer patients. Anticancer Res 25:1291-1296, 2005
Horiguchi J, Koibuchi Y, Iijima K, Yoshida T, Takata D, Rokutanda N, Nagaoka R, Oyama T, Iino Y, Sakurai H, Morishita Y: Local control by breast-conserving surgery with nipple resection. Anticancer Res 25:2957-2959,2005
Horiguchi J, Koibuchi Y, Iijima K, Yoshida T, Takata D, Rokutanda N, Nagaoka R, Oyama T, Iino Y, Morishita Y: Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER-2-positive breast cancer. Oncol Rep 14:1109-1116, 2005